Literature DB >> 21948595

Knowledge transfer and translation: examining how teratogen information is disseminated.

Ilan Shahin1, Adrienne Einarson.   

Abstract

BACKGROUND: Well-executed knowledge transfer and translation (KT) has become a vital part of effective health management. Following the thalidomide disaster, women and their health care providers became fearful of medications and environmental exposures that could affect the health of the unborn child. Therefore, it is important to disseminate evidenced-based information to pregnant women and their health care providers, enabling them to make empowered decisions regarding exposures during pregnancy.
OBJECTIVES: The objectives were twofold: (1) to explore the knowledge transfer process of teratology information from the research community to health care providers, pregnant women, and the general public; and (2) to examine how this impacts pregnant women and their health care providers who require this information.
METHODS: We searched the peer reviewed literature (PUBMED, MEDLINE, and EMBASE), retrieved and examined original studies and review articles, and identified relevant data to evaluate how KT is conducted in this field.
RESULTS: We found that KT and teratology information is very complex, with confusing information, over-estimated fears of teratogenicity, as well as unhelpful, often negatively biased information from the media. Of all the methods we identified, Teratogen Information Services (TIS) appears to conduct the most effective KT approaches in this field.
CONCLUSION: It is evident that KT in this area needs improvement. Women and their health care providers are highly impacted by the type of teratology information they receive, affecting for example, deciding to terminate a wanted pregnancy or discontinue a needed pharmacotherapy. When disseminating information in this very sensitive and complex field, it is imperative that good KT strategies are used, encompassing the availability and appropriate interpretation of information. It is most important that an evidence-based decision is made to ensure the optimal outcome for both the mother and her unborn child.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21948595     DOI: 10.1002/bdra.22851

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  8 in total

1.  Antidepressant use during pregnancy: navigating the sea of information.

Authors:  Adrienne Einarson
Journal:  Can Fam Physician       Date:  2013-09       Impact factor: 3.275

2.  The perils of protection: vulnerability and women in clinical research.

Authors:  Toby Schonfeld
Journal:  Theor Med Bioeth       Date:  2013-06

3.  Multiple information sources and consequences of conflicting information about medicine use during pregnancy: a multinational Internet-based survey.

Authors:  Katri Hämeen-Anttila; Hedvig Nordeng; Esa Kokki; Johanna Jyrkkä; Angela Lupattelli; Kirsti Vainio; Hannes Enlund
Journal:  J Med Internet Res       Date:  2014-02-20       Impact factor: 5.428

4.  Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.

Authors:  Charlotte Gils; Anton Pottegård; Zandra Nymand Ennis; Per Damkier
Journal:  BMC Pregnancy Childbirth       Date:  2016-08-17       Impact factor: 3.007

5.  Quality of life and trust among young people with narcolepsy and their families, after the Pandemrix® vaccination: protocol for a case-control study.

Authors:  Karin Blomberg; Agneta Anderzén Carlsson; Lars Hagberg; Östen Jonsson; Lena Leissner; Mats H Eriksson
Journal:  BMC Pediatr       Date:  2017-08-23       Impact factor: 2.125

6.  Perceived risk of neurodevelopmental outcomes in offspring related to psychotropic and mental illness exposures in pregnancy and breastfeeding: a cross-sectional survey of women with past or current mental illness.

Authors:  Ludvig D Bjørndal; Fatima Tauqeer; Kristin S Heiervang; Hanne K Clausen; Kristine Heitmann; Angela Lupattelli
Journal:  BMJ Open       Date:  2022-09-30       Impact factor: 3.006

7.  A descriptive analysis of calls to the NSW Teratogen Information Service regarding use of anti-infectives during pregnancy.

Authors:  Helen E Ritchie; Elizabeth Hegedus; Joanne Ma; Debra Kennedy
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

8.  Medications and pregnancy: The role of community pharmacists - A descriptive study.

Authors:  Hoi Ying Leung; Bandana Saini; Helen E Ritchie
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.